ALKERMES reported $2.36M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
Amgen AMGN:US $ 464M 1182M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Bristol Myers Squibb BMY:US $ 1055M 966M
Coherus Biosciences CHRS:US $ -29.9M 143.05M
Eli Lilly And LLY:US $ 1390.2M 34.9M
Gilead Sciences GILD:US $ 1522M 207M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
H. Lundbeck A/S LUN:DC 378M 243M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Horizon Pharma HZNP:US $ 158.12M 281.47M
Intra Cellular Therapies ITCI:US $ -68.74M 16M
JAZZ PHA JAZZ:US $ -363.32M 485.15M
Johnson & Johnson JNJ:US $ 6278M 81M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Merk MRK:US $ 1545M 1634M
Minerva Neurosciences NERV:US $ -10.59M 1.78M
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Otsuka Holdings 4578:JP Y 46726M 2043M
Pfizer PFE:US $ 5564M 686M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Revance Therapeutics RVNC:US $ -72.2M 0.56M
Teva Pharmaceutical Industries TEVA:US $ 207M 129M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Zogenix ZGNX:US $ -58.9M 3.27M